Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 10/20 | 0.41 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LAP3 | P28838 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
| ▸ | GCLC | P48506 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27426833 | 0.85 | ALDH1A1 (0.42) | CYP2D6CYP2C9CYP2C19ALDH1A1MEN1 | |
| SCHEMBL7715879 | 0.83 | HSD17B10 (0.38) | CYP2D6CYP2C9CYP2C19FOLH1ALDH1A1 | |
| SCHEMBL27334920 | 0.82 | HSD17B10 (0.51) | CYP2D6CYP2C9CYP2C19FOLH1NAALAD2 | |
| SCHEMBL7718813 | 0.80 | CYP2D6 (0.44) | CYP2D6CYP2C9CYP2C19FOLH1ALDH1A1 | |
| SCHEMBL17504782 | 0.80 | L3MBTL1 (0.46) | CYP2D6CYP2C9CYP2C19FOLH1NAALAD2 | |
| SCHEMBL284647 | 0.79 | ALDH1A1 (0.50) | ALDH1A1MEN1NPC1KMT2AEPHX2 | |
| SCHEMBL7718882 | 0.79 | CYP2D6 (0.39) | CYP2D6CYP2C9CYP2C19ALDH1A1MEN1 | |
| SCHEMBL28237270 | 0.78 | GCLC (0.44) | CYP2D6CYP2C9CYP2C19ALDH1A1MEN1 | |
| SCHEMBL1304145 | 0.78 | FOLH1 (0.64) | FOLH1NAALAD2GCLC | |
| SCHEMBL7717035 | 0.77 | ALDH1A1 (0.48) | CYP2D6CYP2C9CYP2C19ALDH1A1CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536719-B | Synthesis method of high-purity plant source 7-ketolithocholic acid | 江苏佳尔科药业集团股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-105009349-B | Lithium secondary battery | 日立麦克赛尔株式会社 | 2017-09-05 | — | — | CN | disclosed |
| CN-103515666-B | Lithium secondary battery | 日立麦克赛尔株式会社 | 2017-03-01 | — | — | CN | disclosed |
| CN-105576279-A | Lithium secondary battery | HITACHI MAXELL | 2016-05-11 | — | — | CN | disclosed |
| CN-102244294-B | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEMICAL CORP. (JP) | 2015-11-18 | — | — | CN | disclosed |
| CN-105009349-A | Lithium secondary battery | HITACHI MAXELL | 2015-10-28 | — | — | CN | disclosed |
| CN-103647108-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEM CORP | 2014-03-19 | — | — | CN | disclosed |
| CN-103515666-A | Lithium secondary battery | HITACHI MAXELL | 2014-01-15 | — | — | CN | disclosed |
| CN-103038928-A | Lithium secondary battery | HITACHI MAXELL ENERGY LTD | 2013-04-10 | — | — | CN | disclosed |
| CN-102780038-A | Nonaqueous electrolyte battery | MITSUBISHI CHEM CORP | 2012-11-14 | — | — | CN | disclosed |
| CN-102244294-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEM CORP | 2011-11-16 | — | — | CN | disclosed |
| CN-101622751-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEM CORP | 2010-01-06 | — | — | CN | disclosed |
| CN-101454938-A | Nonaqueous electrolyte solution and nonaqueous electrolyte battery | MITSUBISHI CHEM CORP (JP) | 2009-06-10 | — | — | CN | disclosed |
| US-6376512-B1 | FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-23 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |